Skip to main content
COCH
NASDAQ Industrial Applications And Services

Envoy Medical Seeks Shareholder Approval for Reverse Stock Split to Regain Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.74
Mkt Cap
$57.124M
52W Low
$0.363
52W High
$1.89
52W Position info
104% above low
Off High info
61% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

COCH has more than doubled off its 52-week low of $0.363 on light trading volume (0.1× avg).

Summary

Envoy Medical is seeking shareholder approval for a reverse stock split to lift its share price above $1.00 and avoid Nasdaq delisting, with a special meeting set for October 12, 2026.


Key Events · Corporate Governance and Compliance · COCH

  • Reverse Stock Split Proposal

    Board seeks approval to effect a reverse stock split at a ratio of 1-for-5 to 1-for-25, with discretion to implement before December 31, 2026.

  • Nasdaq Compliance Deadline

    Company must regain compliance with the $1.00 minimum bid price rule by November 16, 2026, or face delisting proceedings.

  • Special Meeting Scheduled

    Stockholders will vote on the proposal at a special meeting on October 12, 2026, with a record date of August 19, 2026.

  • Board Recommendation

    The Board unanimously recommends voting FOR the reverse stock split and the adjournment proposal.


Analysis · COCH · Industrial Applications And Services

Envoy Medical is asking shareholders to approve a reverse stock split at a ratio between 1-for-5 and 1-for-25, with the Board having discretion to implement it before December 31, 2026. The company's stock trades at $0.74, below the $1.00 Nasdaq minimum bid price requirement, and it faces delisting if it cannot regain compliance by November 16, 2026. The reverse split is intended to boost the share price above $1.00 and maintain the Nasdaq listing, which is critical for access to capital markets and future financing. However, the proxy statement warns that the split may not sustain a higher price and could lead to further declines, and if the stock falls below $1.00 again within a year, the company faces immediate delisting without another compliance period.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1407 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, COCH was trading at $0.74 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $57.1M. The 52-week trading range was $0.36 to $1.89. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COCH - Latest Insights

COCH
Nov 05, 2026, 1:56 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $7.11 info
Change: +$0.065 (+0.92%) info
Market Cap: $54.95M info
COCH
Nov 05, 2026, 7:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.11 info
Change: -$0.0100 (-0.14%) info
Market Cap: $54.95M info
COCH
Aug 31, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.705
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info
COCH
Aug 10, 2026, 8:31 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.6932
Real-time Price: $7.11 info
Change: Reverse Stock Split info
Market Cap: $54.95M info